Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03574623 · ClinicalTrials.gov registry record · NA

Therapies for Recovery of Hand Function After Stroke

A NA study, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
132
Enrollment target

NCT03574623: Completed NA study, sponsored by MetroHealth Medical Center.

NCT03574623 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03574623, a NA study, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target

Study Summary

After a stroke, it is very common to lose the ability to open the affected hand. The purpose of this study is to compare the effects of three different therapies on recovery of hand function after stroke and determine if any one is better than the other.

Primary Outcome

The BBT is a measure of hand dexterity. It is a count of how many blocks a patient can pick up, move over a barrier, and release in 60 seconds. The higher the score, the better the motor recovery.

Interventions

  • BEHAVIORAL Occupational Therapy
  • DEVICE Electrical Stimulator

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2019-02-15
Est. Completion 2024-10-16
Phase NA
MetroHealth Medical Center

76 total trials

What the finished NCT03574623 record still lists

NCT03574623 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Occupational Therapy is the first listed.

NCT03574623 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03574623 about?

NCT03574623 is a clinical study titled "Therapies for Recovery of Hand Function After Stroke". After a stroke, it is very common to lose the ability to open the affected hand. The purpose of this study is to compare the effects of three different therapies on recovery of hand function after stroke and determine if any one is better than the other.

What is the current status of trial NCT03574623?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2019-02-15. Estimated completion is 2024-10-16.

What interventions are being tested in trial NCT03574623?

The interventions under investigation include: Occupational Therapy (BEHAVIORAL), Electrical Stimulator (DEVICE).

Who is sponsoring clinical trial NCT03574623?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03574623's enrollment target sits among peer trials

132 729th of 2000 higher than 1,269 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03574623, the US trial registry maintained by the National Library of Medicine. NCT03574623 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.